(Q45129016)

English

HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 December 2017

HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase (English)

1 reference

Europe PubMed Central

9 December 2017

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

author name string

Huang Xiao-Jun

1

1 reference

Europe PubMed Central

9 December 2017

Xu Lan-Ping

2

1 reference

Europe PubMed Central

9 December 2017

Liu Kai-Yan

3

1 reference

Europe PubMed Central

9 December 2017

Liu Dai-Hong

4

1 reference

Europe PubMed Central

9 December 2017

Chen Huan

5

1 reference

Europe PubMed Central

9 December 2017

Han Wei

6

1 reference

Europe PubMed Central

9 December 2017

Chen Yu-Hong

7

1 reference

Europe PubMed Central

9 December 2017

Wang Jing-Zhi

8

1 reference

Europe PubMed Central

9 December 2017

Chen Yao

9

1 reference

Europe PubMed Central

9 December 2017

Zhang Xiao-Hui

10

1 reference

Europe PubMed Central

9 December 2017

Shi Hong-Xia

11

1 reference

Europe PubMed Central

9 December 2017

Lu Dao-Pei

12

1 reference

Europe PubMed Central

9 December 2017

language of work or name

0 references

publication date

1 January 2008

1 reference

Europe PubMed Central

9 December 2017

Annals of Medicine

1 reference

Europe PubMed Central

9 December 2017

40

1 reference

Europe PubMed Central

9 December 2017

6

1 reference

Europe PubMed Central

9 December 2017

444-455

1 reference

Europe PubMed Central

9 December 2017

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib era.

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: estab

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Haploidentical stem cell transplantation for acute leukemia.

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance

1 reference

https://api.crossref.org/works/10.1080%2F07853890801908903

21 January 2018

Identifiers

10.1080/07853890801908903

1 reference

Europe PubMed Central

9 December 2017

1 reference

Europe PubMed Central

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45129016&oldid=2066671801"